Antibiotics can disrupt gut microbiota, leading to potential recurrences of Clostridioides difficile infections (CDI). New therapies like fecal microbiota transplantation (FMT) and monoclonal ...
Clostridioides difficile (C. diff) is a type of bacteria that may lead to severe diarrhea and colon inflammation. It’s often associated with taking antibiotics. According to the Centers for ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...
At least 10,000 FMT procedures for rCDI are performed each year, using screened stool from healthy donors. After a person with a C. diff infection gets treated with antibiotics, there is about a 25 ...
with its lead antibiotic candidate, ibezapolstat, preparing to advance to international Phase 3 clinical trials to treat patients with C. difficile Infection (CDI). The Company today announced updates ...
Healthcare Professionals: It’s C. diff Awareness Month. Antibiotics are life-saving drugs, but their use increases your patient’s risk of C. diff infection. Prescribe the most targeted ...